Barbara Fowble1, Catherine Park2, Frederick Wang3, Anne Peled3, Michael Alvarado4, Cheryl Ewing4, Laura Esserman4, Robert Foster3, Hani Sbitany3, Alex Hanlon5. 1. Department of Radiation Oncology, University of California San Francisco, San Francisco, California. Electronic address: BFowble@radonc.ucsf.edu. 2. Department of Radiation Oncology, University of California San Francisco, San Francisco, California. 3. Division of Plastic and Reconstructive Surgery, University of California San Francisco, San Francisco, California. 4. Carol Franc Buck Breast Care Center, Department of Surgery, University of California San Francisco, San Francisco, California. 5. University of Pennsylvania School of Nursing, Philadelphia, Pennsylvania.
Abstract
OBJECTIVES: Mastectomy rates for breast cancer have increased, with a parallel increase in immediate reconstruction. For some women, tissue expander and implant (TE/I) reconstruction is the preferred or sole option. This retrospective study examined the rate of TE/I reconstruction failure (ie, removal of the TE or I with the inability to replace it resulting in no final reconstruction or autologous tissue reconstruction) in patients receiving postmastectomy radiation therapy (PMRT). METHODS AND MATERIALS: Between 2004 and 2012, 99 women had skin-sparing mastectomies (SSM) or total nipple/areolar skin-sparing mastectomies (TSSM) with immediate TE/I reconstruction and PMRT for pathologic stage II to III breast cancer. Ninety-seven percent had chemotherapy (doxorubicin and taxane-based), 22% underwent targeted therapies, and 78% had endocrine therapy. Radiation consisted of 5000 cGy given in 180 to 200 cGy to the reconstructed breast with or without treatment to the supraclavicular nodes. Median follow-up was 3.8 years. RESULTS: Total TE/I failure was 18% (12% without final reconstruction, 6% converted to autologous reconstruction). In univariate analysis, the strongest predictor of reconstruction failure (RF) was absence of total TE/I coverage (acellular dermal matrix and/or serratus muscle) at the time of radiation. RF occurred in 32.5% of patients without total coverage compared to 9% with coverage (P=.0069). For women with total coverage, the location of the mastectomy scar in the inframammary fold region was associated with higher RF (19% vs 0%, P=.0189). In multivariate analysis, weight was a significant factor for RF, with lower weight associated with a higher RF. Weight appeared to be a surrogate for the interaction of total coverage, thin skin flaps, interval to exchange, and location of the mastectomy scar. CONCLUSIONS: RFs in patients receiving PMRT were lowered with total TE/I coverage at the time of radiation by avoiding inframammary fold incisions and with a preferred interval of 6 months to exchange.
OBJECTIVES: Mastectomy rates for breast cancer have increased, with a parallel increase in immediate reconstruction. For some women, tissue expander and implant (TE/I) reconstruction is the preferred or sole option. This retrospective study examined the rate of TE/I reconstruction failure (ie, removal of the TE or I with the inability to replace it resulting in no final reconstruction or autologous tissue reconstruction) in patients receiving postmastectomy radiation therapy (PMRT). METHODS AND MATERIALS: Between 2004 and 2012, 99 women had skin-sparing mastectomies (SSM) or total nipple/areolar skin-sparing mastectomies (TSSM) with immediate TE/I reconstruction and PMRT for pathologic stage II to III breast cancer. Ninety-seven percent had chemotherapy (doxorubicin and taxane-based), 22% underwent targeted therapies, and 78% had endocrine therapy. Radiation consisted of 5000 cGy given in 180 to 200 cGy to the reconstructed breast with or without treatment to the supraclavicular nodes. Median follow-up was 3.8 years. RESULTS: Total TE/I failure was 18% (12% without final reconstruction, 6% converted to autologous reconstruction). In univariate analysis, the strongest predictor of reconstruction failure (RF) was absence of total TE/I coverage (acellular dermal matrix and/or serratus muscle) at the time of radiation. RF occurred in 32.5% of patients without total coverage compared to 9% with coverage (P=.0069). For women with total coverage, the location of the mastectomy scar in the inframammary fold region was associated with higher RF (19% vs 0%, P=.0189). In multivariate analysis, weight was a significant factor for RF, with lower weight associated with a higher RF. Weight appeared to be a surrogate for the interaction of total coverage, thin skin flaps, interval to exchange, and location of the mastectomy scar. CONCLUSIONS: RFs in patients receiving PMRT were lowered with total TE/I coverage at the time of radiation by avoiding inframammary fold incisions and with a preferred interval of 6 months to exchange.
Authors: Nalee Kim; Haeyoung Kim; Won Park; Doo Ho Choi; Won Kyung Cho; Seok Jin Nam; Jeong Eon Lee; Seok Won Kim; Jonghan Yu; Sei Kyung Lee; Byung-Joon Jeon; Jai Kyong Pyon; Goo-Hyun Mun; Tae Gyu Kim Journal: Breast Cancer Res Treat Date: 2022-01-16 Impact factor: 4.872
Authors: Jie Jane Chen; Rie von Eyben; Paulina M Gutkin; Erin Hawley; Frederick M Dirbas; Gordon K Lee; Kathleen C Horst Journal: Ann Surg Oncol Date: 2020-09-01 Impact factor: 5.344
Authors: Maria Cecilia Closs Ono; Anne Karoline Groth; Alfredo Benjamin Duarte da Silva; Renato da Silva Freitas; Christiane Sayuri Kawasaki; Dayane Raquel de Paula; Maria Alice Zarate Nissel Journal: Gland Surg Date: 2019-08
Authors: Víctor Fuertes; Mónica Francés; José M Casarrubios; Javier Fernández-Palacios; Jesús María González; Juan Francisco Loro-Ferrer Journal: Gland Surg Date: 2020-04
Authors: Ashley L Howarth; Joshua R Niska; Kenneth Brooks; Aman Anand; Martin Bues; Carlos E Vargas; Raman C Mahabir Journal: Plast Reconstr Surg Glob Open Date: 2017-06-23
Authors: Alfred P Yoon; Ji Qi; Hyungjin M Kim; Jennifer B Hamill; Reshma Jagsi; Andrea L Pusic; Edwin G Wilkins; Jeffrey H Kozlow Journal: Plast Reconstr Surg Date: 2020-05 Impact factor: 5.169